Dr. Christopher S.r. Dakhil, MD

Dr. Dakhil practices at The Center for Same Day Surgery in Wichita, Kansas.

Dr. Dakhil's NPI, 1972721348, was assigned on April 23, 2007. Dr. Dakhil graduated from University of Kansas School of Med (KC/Wich/Sal) in 2006. Dr. Dakhil holds Kansas license 0433742.

Dr. Dakhil's primary practice is The Center for Same Day Surgery, at 818 N Emporia Cir, Wichita, KS 67214 in Sedgwick County. The practice phone is (316) 262-7263.

Dr. Dakhil's primary practice is The Center for Same Day Surgery in Wichita, Kansas. Dr. Dakhil is also affiliated with Ascension Via Christi St. Francis. The medical group on file is Cancer Center of Kansas. Dmand AI also links Dr. Dakhil to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dakhil practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dakhil's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Dakhil is licensed in Kansas.

CMS data shows 374,997 Medicare services from Dr. Dakhil across 90 procedure codes in 2024, for 1,413 Medicare patients. Medicare paid $6,139,258 for them.

CMS counts 1,413 Medicare patients who saw Dr. Dakhil in 2024. The largest group is 65 to 74, with 685 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dakhil's median patient age at 72, with 60% women.

In 2024, Dr. Dakhil wrote 1,959 Medicare Part D claims for 339 patients. 87% of them were for generic drugs. CMS names the drug for 1,777 of them, across 37 drugs with 11 or more claims each, at $2,164,459 in total drug cost. In 2023, CMS named 1,633 claims across 31 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Dakhil for performance year 2024, reported as part of a group. Dr. Dakhil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dakhil as offering telehealth.

Dmand AI links 14 papers to Dr. Dakhil, published from 2013 to 2022. 2014 was the busiest year, with 2. The most frequent topics are Biopsy, Biomarkers, Tumor and Lung Neoplasms. Dr. Dakhil's most frequent co-authors are Richy Agajanian, MD, Michael W. Cannon, MD and Jeremy M. Deutsch, MD.

CMS Open Payments shows 1,576 general payments to Dr. Dakhil from 103 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 49% of the total. Daiichi Sankyo Inc. paid the most, $30,496. It also lists 2 research payments totaling $3,442 from 2017 to 2022.

Dr. Dakhil graduated from University of Kansas School of Med (KC/Wich/Sal) in 2006.